New cohorts in PSC and PHSR arrive as the School launches curriculum updates and deepens its commitment to research and student success.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

Ceremonies honor six academic programs and the next generation of health care leaders, researchers, and advocates .

Leadership role provides oversight for grant and contract submissions and identification of funding sources and initiates collaborative and translational research programs.

New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

Pharmaceutical scientist aims to foster continued collaborations and drive interdisciplinary research.

Team approach is a win-win for researchers, patients.

Diverse cohort of scholars represent seven graduate programs.

Research from the lab of Jana Shen looks at a mutation causing diminished effectiveness of Paxlovid.

The daylong event featured career panels and networking opportunities.

The PhD and MS in PSC and PhD in PHSR programs have changed leadership.

Since June, Michel has served as interim dean and was previously chair of the Department of Pharmaceutical Sciences and associate dean for graduate programs.